Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

A social media listening study of patients¿ experiences relating to metabolic dysfunction-associated steatotic liver disease: The LISTEN-MASLD study Jeffrey V. Lazarus; William Alazawi; Ron Basuroy; Laurent Castera; Dmitry Estulin; Yiannoula Koulla; Preethy Prasad; Manuel Romero-Gomez; Hirokazu Takahashi; Vincent Wai-Sun Wong; Jörn M. Schattenberg;

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease Chenyang Mu; Sijie Wang; Zenghan Wang; Jian Tan; Haozan Yin; Yuefan Wang; Zhihui Dai; Dongyang Ding; Fu Yang;